Showing results (241-250 of 345) with videos related to

Sort By:
Pageof 35
American Journal of Physiology. Endocrinology and Metabolism|August 1, 2013
Protein kinase C-induced activin A switches adrenocortical steroidogenesis to aldosterone by suppressing CYP17A1 expressionJohannes Hofland, Jacobie Steenbergen, Leo J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cellsW W de Herder, L J Hofland, T B Usdin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2018
Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 ExpressionAmmar Muhammad, Eva C Coopmans, Federico Gatto, et al.
Journal of Endocrinological Investigation|October 28, 2004
There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patientsJ A M J L Janssen, D Poldermans, L J Hofland, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
In vivo and in vitro detection of dopamine d2 receptors in uveal melanomasLisa Bodei, Leo J Hofland, Diego Ferone, et al.
Clinical Epigenetics|June 28, 2018
Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancerFleur S Peters, Annemiek M A Peeters, Pooja R Mandaviya, et al.
Endocrine-Related Cancer|March 16, 2012
The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cellsMaria Cristina De Martino, Peter M van Koetsveld, Richard A Feelders, et al.
British Journal of Cancer|March 16, 2016
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitorsTimon Vandamme, Matthias Beyens, Ken Op de Beeck, et al.
Pageof 35